Experimental and clinical study on ATP-MgCl2 administration for postischemic acute renal failure. 1983

H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato

The present study was undertaken to investigate the effect of ATP-MgCl2 on the recovery of renal function following renal ischemia. Bilateral renal ischemia was produced for 90 minutes in dogs. Immediately after the release of ischemia, ATP-MgCl2 (50 mumoles/kg) was given intravenously. Serum creatinine and FeNa were measured following the release of ischemia. Renal cellular energy charge, glomerular endothelial thickness and per cent circularity of interstitial cells were measured. Creatinine and FeNa were significantly lower in ATP-MgCl2 treated dogs compared to those in saline treated controls. Changes in energy charge, glomerular endothelial thickness and per cent circularity indicated ischemically induced renal cellular edema was reversed with ATP-MgCl2 through the improvement of energy metabolism. Taking those experimental data into consideration, ATP-MgCl2 was given to 16 acute renal failure patients and 13 patients survived. ATP-MgCl2 administration is effective for the treatment of acute renal failure.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
July 1983, Nihon Jinzo Gakkai shi,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
January 1964, Orvosi hetilap,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
May 1986, The American journal of physiology,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
October 1983, The American journal of physiology,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
November 1986, Biochimica et biophysica acta,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
January 2003, Neurosurgical review,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
March 2000, Panminerva medica,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
February 1987, The American journal of physiology,
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
November 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
H Hirasawa, and M Odaka, and K Soeda, and H Kobayashi, and Y Ohtake, and S Oda, and S Kobayashi, and H Sato
October 1976, Kidney international. Supplement,
Copied contents to your clipboard!